Purification and bioactivity of exendin-4, a peptide analogue of GLP-1, expressed in Pichia pastoris

被引：0
|
作者：
Jin Zhou
Ju Chu
Yong-Hong Wang
Hui Wang
Ying-Ping Zhuang
Si-Liang Zhang
机构：
[1] East China University of Science & Technology,State Key Laboratory of Bioreactor Engineering, National Engineering Research Center for Biotechnology (Shanghai)
来源：
Biotechnology Letters | 2008年 / 30卷
关键词：
Diabetes; Exendin-4; Glucagon peptide analogue;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Exendin-4, a peptide analogue of glucagon-like peptide-1 (GLP-1), has been developed for treatment of type 2 diabetes. Herein, the secretive exendin-4 fusion protein, expressed by methanol induction in Pichia pastoris system, was purified to homogeneity by chromatography followed by enterokinase cleavage of the fusion protein and subsequent purification of the recombinant exendin-4. Purity of the recombinant exendin-4 was 95.6%. Bioactivity assay revealed that it had glucose-lowering and insulin-releasing action in vivo.
引用
收藏
页码：651 / 656
页数：5
相关论文
共 50 条
  • [31] Brain Site-Specific Inhibitory Effects of the GLP-1 Analogue Exendin-4 on Alcohol Intake and Operant Responding for Palatable Food
    Colvin, Kayla J.
    Killen, Henry S.
    Kanter, Maxwell J.
    Halperin, Maximilian C.
    Engel, Liv
    Currie, Paul J.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (24) : 1 - 15
  • [32] Acute injection of the GLP-1 analogue Exendin-4 in the olfactory bulb improves glucose tolerance in diet-induced obese mice
    Montaner, M.
    Denom, J.
    Emery-Fillon, N.
    Magnan, C.
    Gurden, H.
    Migrenne-Li, S.
    DIABETOLOGIA, 2019, 62 : S232 - S232
  • [33] Exendin-4 stimulated increase in small intestinal mass in mice is mediated by the GLP-1 receptor
    Simonsen, Lotte
    Baggio, Laurie L.
    Yusta, Bernardo
    Drucker, Daniel J.
    Holst, Jens J.
    Deacon, Carolyn F.
    DIABETES, 2008, 57 : A404 - A405
  • [34] OLEATE CONTROLS THE EFFECTS OF GLP-1 AND EXENDIN-4 ON MYOCARDIAL GLUCOSE UTILIZATION AND CONTRACTILE FUNCTION
    Tien Nguyen
    Shingu, Yasushige
    Amorim, Paulo A.
    Schwarzer, Michael
    Doenst, Torsten
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E211 - E211
  • [35] GLP-1/Exendin-4 induces β-cell proliferation via the epidermal growth factor receptor
    Fusco, Joseph
    Xiao, Xiangwei
    Prasadan, Krishna
    Sheng, Qingfeng
    Chen, Congde
    Ming, Yung-Ching
    Gittes, George
    SCIENTIFIC REPORTS, 2017, 7
  • [36] Exendin-4, a GLP-1 receptor agonist, stimulates rat pituitary-adrenocortical axis
    Malendowicz, LK
    Nowak, KW
    Nussdorfer, GG
    Zyterska, A
    Rebuffat, P
    Nowak, M
    BIOMEDICAL RESEARCH-TOKYO, 2001, 22 (06): : 273 - 276
  • [37] Comparison of glucose lowering effects of exendin-4 and GLP-1 in diabetic db/db mice
    Bhavsar, S
    Lachappell, R
    Watkins, J
    Young, A
    DIABETES, 1998, 47 : A192 - A192
  • [38] The glucagon-like peptide 1 (GLP-1) receptor agonist exendin-4 reduces cocaine self-administration in mice
    Sorensen, Gunnar
    Reddy, India A.
    Weikop, Pia
    Graham, Devon L.
    Stanwood, Gregg D.
    Wortwein, Gitta
    Galli, Aurelio
    Fink-Jensen, Anders
    PHYSIOLOGY & BEHAVIOR, 2015, 149 : 262 - 268
  • [39] GLP-1/Exendin-4 induces β-cell proliferation via the epidermal growth factor receptor
    Joseph Fusco
    Xiangwei Xiao
    Krishna Prasadan
    Qingfeng Sheng
    Congde Chen
    Yung-Ching Ming
    George Gittes
    Scientific Reports, 7
  • [40] α-Helix or β-Turn? An Investigation into N-Terminally Constrained Analogues of Glucagon-like Peptide 1 (GLP-1) and Exendin-4
    Oddo, Alberto
    Mortensen, Sofia
    Thogersen, Henning
    De Maria, Leonardo
    Hennen, Stephanie
    McGuire, James N.
    Kofoed, Jacob
    Linderoth, Lars
    Reedtz-Runge, Steffen
    BIOCHEMISTRY, 2018, 57 (28) : 4148 - 4154
12345